全球医药巨头缩编！赛默飞世尔再裁300人

生物科技馆2025-02-05

尽管近期财务状况有所改善，赛默飞世尔（Thermo Fisher）的裁员行动仍在持续。根据FiercePharma的报道，美国马萨诸塞州工人调整和再培训通知（WARN）显示，该公司计划在其剑桥和普莱恩维尔的病毒载体制造工厂裁减300名员工，裁员将于2025年3月30日生效。赛默飞世尔通过电子邮件向媒体确认了这一裁员计划，但未提供更多细节。公司发言人表示：“我们不断评估提升运营效率和优化客户服务的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2509447101?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-05 11:33","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2509447101","market":"us","top_or_hot":-1,"title":"全球医药巨头缩编！赛默飞世尔再裁300人","media":"生物科技馆","content":"<div>\n<p>尽管近期财务状况有所改善，赛默飞世尔（Thermo Fisher）的裁员行动仍在持续。根据FiercePharma的报道，美国马萨诸塞州工人调整和再培训通知（WARN）显示，该公司计划在其剑桥和普莱恩维尔的病毒载体制造工厂裁减300名员工，裁员将于2025年3月30日生效。赛默飞世尔通过电子邮件向媒体确认了这一裁员计划，但未提供更多细节。公司发言人表示：“我们不断评估提升运营效率和优化客户服务的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205114052abc2cd92&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>全球医药巨头缩编！赛默飞世尔再裁300人</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n全球医药巨头缩编！赛默飞世尔再裁300人\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-05 11:33 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205114052abc2cd92&s=b><strong>生物科技馆</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>尽管近期财务状况有所改善，赛默飞世尔（Thermo Fisher）的裁员行动仍在持续。根据FiercePharma的报道，美国马萨诸塞州工人调整和再培训通知（WARN）显示，该公司计划在其剑桥和普莱恩维尔的病毒载体制造工厂裁减300名员工，裁员将于2025年3月30日生效。赛默飞世尔通过电子邮件向媒体确认了这一裁员计划，但未提供更多细节。公司发言人表示：“我们不断评估提升运营效率和优化客户服务的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205114052abc2cd92&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2092937221.SGD","symbol_name":"Blackrock Circular Economy A2 SGD-H","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205114052abc2cd92&s=b","article_id":"2509447101","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205114052abc2cd92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2509447101","pubTimestamp":1738726407,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"尽管近期财务状况有所改善，赛默飞世尔的裁员行动仍在持续。赛默飞世尔通过电子邮件向媒体确认了这一裁员计划，但未提供更多细节。此次裁员是赛默飞世尔近期一系列调整的一部分。这一举措导致列克星敦、剑桥和普莱恩维尔三地共裁减160个岗位。疫情期间，赛默飞世尔因药品制造需求激增而迅速扩张。赛默飞世尔在2019年以17亿美元收购病毒载体生产商Brammer Bio时获得了列克星敦设施。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2092937221.SGD":"Blackrock Circular Economy A2 SGD-H","LU0096362180.USD":"CT (LUX) I GLOBAL FOCUS \"DU\" (USD)","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC","LU1854104046.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) ACC","LU1923622614.USD":"Natixis Thematics Meta R/A USD","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","LU0342679015.USD":"ALLIANZ GLOBAL EQUITY UNCONSTRAINED \"AT\" (USD) ACC","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU0011850046.USD":"贝莱德全球长线股票 A2 USD","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","IE00B19Z8X17.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH  \"AG\" (USD) ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0122379950.USD":"贝莱德世界健康科学A2","BK4534":"瑞士信贷持仓","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","BK4585":"ETF&股票定投概念","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU2211814178.USD":"ALLIANZ CLEAN PLANET \"AT\" (USD) ACC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","BK4566":"资本集团","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU2360108059.USD":"BGF CIRCULAR ECONOMY \"A4\" (USD) INC","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU2125909916.SGD":"Natixis Thematics Safety R/A SGD","TMO":"赛默飞世尔","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU0061474960.USD":"天利环球焦点基金AU Acc","LU0557290698.USD":"施罗德环球可持续增长基金","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU2764262908.HKD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (HKD) ACC","LU2298321311.HKD":"BGF CIRCULAR ECONOMY \"A\" (HKDHDG) ACC","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU2125909759.SGD":"Natixis Thematics Safety H-R/A SGD","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","BK4588":"碎股","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU2041044095.USD":"Blackrock Circular Economy A2 USD"},"translate_title":"Global pharmaceutical giants downsize! Thermo Fisher lays off 300 more people","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMO":1},"content_text":"尽管近期财务状况有所改善，赛默飞世尔（Thermo Fisher）的裁员行动仍在持续。根据FiercePharma的报道，美国马萨诸塞州工人调整和再培训通知（WARN）显示，该公司计划在其剑桥和普莱恩维尔的病毒载体制造工厂裁减300名员工，裁员将于2025年3月30日生效。赛默飞世尔通过电子邮件向媒体确认了这一裁员计划，但未提供更多细节。公司发言人表示：“我们不断评估提升运营效率和优化客户服务的机会。鉴于客户需求和时间安排的变化，我们正在进行战略性业务调整。”此次裁员是赛默飞世尔近期一系列调整的一部分。不到三个月前，公司宣布关闭其位于马萨诸塞州列克星敦的病毒载体制造工厂，并将业务整合至2022年开放的普莱恩维尔新园区。这一举措导致列克星敦、剑桥和普莱恩维尔三地共裁减160个岗位。疫情期间，赛默飞世尔因药品制造需求激增而迅速扩张。2021年，公司员工人数从约8万增至约13万，并完成了五次收购，包括以174亿美元收购合同研究组织PPD。从2017年到2022年，公司年收入从209亿美元增长至449亿美元。然而，过去两年收入稳定在429亿美元。公司预计2025年收入将在435亿至440亿美元之间。赛默飞世尔的发展轨迹反映了合同开发和制造组织（CDMO）行业的普遍趋势。除了马萨诸塞州的裁员，公司还在2023年4月裁减了加利福尼亚州卡尔斯巴德质粒制造实验室的74个岗位，并于2022年关闭了新泽西州普林斯顿的生物制剂开发和细胞治疗服务设施，解雇了113名员工。此外，2023年8月，公司在佛罗里达州阿拉丘亚的两个办公点裁减了200多名员工。赛默飞世尔在2019年以17亿美元收购病毒载体生产商Brammer Bio时获得了列克星敦设施。此次收购还包括剑桥和列克星敦的商业化病毒载体工厂，以及阿拉丘亚的临床前和临床阶段站点。素材来源官方媒体/网络新闻近期峰会活动","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2509447101","isCrawlerRequest":true}